Stockholm, Sweden-based Elekta develops precision radiation therapy to treat cancer. The FDA cleared its latest offering, the Comprehensive Motion Management (CMM) with True Tracking and automatic gating, earlier this year.
Krishna Institute of Medical Sciences (KIMS) in Hyderabad, one of India’s largest corporate healthcare groups, made the order. Dr. Bhaskar Rao Bollineni, KIMS chair and managing director, called Elekta’s technologies “cutting edge.”
“These devices and software will enable us to provide more personalized and precise treatments for various types of cancers, while minimizing side effects and improving quality of life,” said Bollineni. “We are committed to offering the best possible care to our patients and investi…